Mirae Asset Global Etfs Holdings Ltd. Alkermes Plc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Alkermes Plc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 99,721 shares of ALKS stock, worth $2.95 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
99,721
Previous 95,465
4.46%
Holding current value
$2.95 Million
Previous $2.3 Million
21.35%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ALKS
# of Institutions
362Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$860 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$561 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$384 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$374 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$271 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.85B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...